Is the success rate of assisted reproduction in Kyrgyzstan high? Don't just look at the publicity data, the key is to look at these six factors.

When many people know about overseas assisted reproduction, they will directly search: "Is the success rate of assisted reproduction in Kyrgyzstan high?" It is not difficult to see some attractive data on the internet.

But what really needs to be vigilant is to summarize the treatment results of all people with only one figure.

Assisted reproduction does not automatically improve the chances of success by changing a country and choosing a hospital. Age, ovarian reserve, sperm quality, embryo development, uterine conditions, laboratory level and treatment plan will all change the final result.

Therefore, the more accurate answer is:

Some assisted reproductive institutions in Kyrgyzstan have the conditions to carry out in vitro fertilization, sperm injection, blastocyst culture, embryo freezing and embryo genetic testing, but whether a patient can finally get the ideal result can not be judged only by the country name or the success rate in hospital publicity.

Users think that the higher the success rate, the more worthwhile the hospital is.

This is a misunderstanding that many cross-border patients are easy to enter.

It also says "success rate", which may correspond to a completely different statistical method. Some count clinical pregnancy, some count embryo implantation, some count patients in hospital, some only count people who have completed transplantation, and some count young patients and elderly patients together.

These data seem to be "success rate", but the actual meaning is not the same.

What do common data names stand for? Is it equal to the final birth result?

Fertilization rate The proportion of mature eggs that have completed fertilization is not equal to

The rate of blastocyst formation from embryo culture to blastocyst stage is not equal to

Embryo implantation rate The rate of implantation of transplanted embryos is not equal to

Ultrasonic examination of clinical pregnancy rate confirms that gestational sac or fetal heart is not equal to

The live birth rate of a single transplant is of great reference value.

Cumulative live birth rate of all available embryos formed by taking eggs at one time, and the comprehensive results in subsequent transfer are more suitable for evaluating the complete cycle

For example, one hospital publishes the clinical pregnancy of young patients, and the other publishes the cumulative live birth results of patients of all ages. The two groups of figures cannot be directly compared together.

Therefore, when consulting the test tube hospital in Kyrgyzstan, you should not only ask "What is your success rate", but also continue to ask:

Is it pregnancy or live birth?

According to the egg retrieval cycle or according to the transplantation cycle?

Is there a distinction between age and ovarian reserve?

Does it include patients who canceled their cycles and did not form transplantable embryos?

Only when the statistical caliber is close, the data has comparative significance.

Actual situation: It is often not the country that decides the result, but these six variables.

Age and germ cell quality

Age is an unavoidable factor in evaluating the outcome of assisted reproduction. With the increase of age, the number of collectable follicles in the ovary may decrease, and the quality of germ cells and the normal probability of embryo chromosomes may also change.

This means that people who also receive assisted reproduction in Kyrgyzstan, who are about 30 years old and have normal ovarian reserves, and those over 40 years old who have failed many times in the past cannot use the same set of success rate data.

Older people should pay more attention not to the average given by the hospital, but to:

The treatment results of patients of the same age;

Number of eggs obtained and maturity;

Blastocyst formation;

Whether it is necessary to complete the treatment in stages;

Does the doctor explain in advance the possibility of cycle cancellation or unavailability of embryos?

Ovarian reserve and ovulation induction reaction

AMH, the number of basal follicles and basic hormones can help doctors to judge the response of ovaries to drug stimulation, but they can't predict whether they can finally get a live birth.

Some patients have low AMH, but they may still get embryos with developmental potential; Some patients have a large number of follicles, but there may be problems such as unsatisfactory maturation rate, fertilization rate or embryo development.

Therefore, a responsible assessment usually does not only look at one indicator, but also analyzes age, menstrual condition, previous records of ovulation promotion, basal follicles, hormone levels and previous embryo results together.

Embryo laboratory ability

Many people only pay attention to doctors when choosing hospitals, but ignore embryo laboratories.

From the culture environment, micro-operation, culture solution management after egg retrieval to blastocyst culture, frozen resuscitation and embryo observation, it will affect the stable development of embryos. Laboratory management includes not only the availability of equipment, but also personnel experience, operating specifications, temperature and gas control, sample checking and quality management.

Before going to Kyrgyzstan for treatment, you can focus on:

Whether the laboratory is in the charge of the fixed embryology team;

Whether there are conditions for blastocyst culture and vitrification;

Whether the embryo culture information can be completely recorded;

Whether the freezing, preservation and recovery processes are clear;

Whether the culture strategy will be decided according to the quantity and quality of embryos.

Just because a hospital can develop a certain technology does not mean that every patient needs to use it. Whether the technology is suitable or not should be determined by the specific etiology and treatment objectives.

Uterine environment and transplant opportunity

The formation of usable embryos is only one step in the treatment process.

The thickness and shape of endometrium, uterine cavity condition, hormone level, chronic inflammation, adenomyosis, endometriosis and previous uterine cavity operation history may all affect the transplant arrangement.

Some patients are not suitable for immediate transplantation after egg retrieval, but need physical recovery, uterine cavity evaluation or endometrial preparation first. If the hospital enters the transplant stage in pursuit of faster, ignoring individual conditions may reduce the cycle utilization efficiency.

Therefore, what really deserves attention is whether the doctor will adjust the time according to his physical condition, not whether he can transplant it as soon as possible.

Is the male factor completely evaluated?

The failure of assisted reproduction is not only related to women.

Sperm concentration, motility, morphology and sperm DNA integrity may affect fertilization and embryo development. Especially when the fertilization rate is low, embryo abortion or blastocyst formation is difficult in the past, the man's examination should not only stay in the ordinary semen analysis.

An institution with clear treatment logic will evaluate both sides at the same time, instead of attributing all problems to age, endometrium or ovarian function.

Is the scheme truly individualized?

The "individualized plan" is not simply to change the name of the drug, nor does it increase the testing items for all patients.

True individualized treatment should be based on past medical history, examination results, drug response and embryo outcome. For example:

For those with low ovarian response, the key point is to improve the cycle utilization efficiency;

People with polycystic ovary need to pay attention to ovulation-promoting reaction and physical safety;

Patients with severe male factors need to formulate more targeted fertilization programs;

If the repeated transplantation is unsuccessful, the factors of embryo and uterine cavity should be combed again;

People with a history of genetic diseases or chromosome problems need genetic counseling before determining the path.

The more projects, the better the results. Additional technology without clear indications may increase the complexity of the process, but it may not necessarily bring corresponding benefits.

A more practical judgment model: Don't ask "Is it high?" Look at "Is it suitable for me?"

To judge whether assisted reproduction in Kyrgyzstan is worth considering, we can analyze it according to the following four paths.

Path A: Basic conditions are relatively stable.

The age is relatively young, the ovarian reserve is acceptable, the uterine cavity is clear, and there is no obvious abnormality in the man's examination. This kind of people usually need to pay attention to the hospital basic treatment process, embryo laboratory and communication efficiency, and do not have to chase complex technology excessively.

Path B: Old age or declining ovarian reserve

The emphasis should be shifted from "average success rate in hospitals" to "whether available embryos can be obtained". During the consultation, it is necessary to know how the doctor evaluates the cycle value, whether the plan will be adjusted according to the previous drug response, and how to deal with the limited number of eggs obtained.

Path C: Repeated failure or repeated fetal arrest

You cannot simply copy the previous cycle scheme. It is necessary to re-examine the embryo factor, uterine cavity factor, endometrial preparation, male factor and genetic risk. If the hospital does not analyze the causes of previous failures and only emphasizes that the results will improve after changing countries, it should be judged cautiously.

Path D: There is a definite genetic problem.

Genetic counseling should be completed first to judge whether the relevant tests have medical indications, and to understand the relationship between embryo testing, result interpretation, transplant selection and subsequent prenatal examination, rather than understanding embryo testing as a general tool to improve the success rate.

The core of this decision-making model is that choosing a country is only a path choice, and individual conditions and medical execution are the basis of the result.

How to verify the data published by Kyrgyz hospitals?

It is often difficult for ordinary users to obtain a unified database covering all institutions in Kyrgyzstan, stratified by age and ending with live births in public channels. Therefore, the data published by institutions themselves can be used as preliminary information, but it is not suitable for independent use without statistical caliber.

When consulting, you can ask the other party to explain the following information:

The specific year and sample number of data statistics;

Whether to distinguish between different age groups;

Whether it includes patients with first-time treatment and repeated failures;

The statistical end point is pregnancy test, clinical pregnancy or live birth;

Whether it is single transplantation data or complete egg retrieval cycle data;

Whether to rule out the cycle of not getting eggs, not forming embryos or canceling transplantation.

If the other party can only emphasize a very high number repeatedly, but can't explain the sample, age, period and statistical end point, the decision-making value of this number is usually limited.

Users are also concerned about: how to reduce the judgment bias when going to Kyrgyzstan for assisted reproduction.

Check normal, is there a high chance of success?

Not necessarily. Normal routine examination can only show that no obvious abnormality has been found, which can not fully reflect the quality of germ cells, embryonic development potential and subsequent transplantation results. Medical evaluation can only narrow the uncertainty, but not eliminate it.

Can embryonic genetic testing improve the success rate?

Need to see the indications. It can help some people with genetic risk, old age or specific medical history to identify the chromosome situation of embryos, but it can't improve the quality of embryos themselves, and it can't guarantee the ideal results after transplantation.

There are many cases in hospitals, does it mean that the technology is better?

The number of cases can reflect the experience of receiving medical treatment, but it cannot replace the normative data. It also depends on whether the case is similar to one's age, etiology and treatment experience, and whether the hospital truthfully presents the unsuccessful cycle and possible risks.

Should we choose a country or make an evaluation first?

A more reasonable order is to complete the basic examination and cause sorting first, and then judge whether the medical resources, medical treatment process and service model in Kyrgyzstan match. If the destination is determined first, and then the scheme is reluctantly applied, it is easy to cause the decision to be reversed.

Is the success rate of assisted reproduction in Kyrgyzstan high? In the end, it cannot be simply summarized by the words "high" or "not high".

For people with good basic conditions and clear treatment paths, some local institutions can provide corresponding assisted reproductive services; For the elderly, declining ovarian reserve, serious male factors, genetic problems or repeated failures, it needs to be more carefully evaluated.

What is really worth comparing when choosing is whether the hospital interprets the data truthfully, whether it can complete the system inspection, whether the laboratory management is clear, whether the scheme is adjusted according to individual circumstances, and whether there is a clear re-checking mechanism after failure.

Instead of looking for a beautiful success rate, it is better to find out first: who is this figure, where it is counted, and whether you belong to a similar population.